Brewins profits jump despite advisory outflows
The wealth manager saw a 215% jump in pre-tax profits as redundancy costs fell and discretionary AUM rose.
The wealth manager saw a 215% jump in pre-tax profits as redundancy costs fell and discretionary AUM rose.
|
|
River and Mercantile and Lloyds TSB deals may be key to asset manager and bank floats in 2014
|
|
Fundsmith is seeking to raise between £100m and £250m in order to launch its new Emerging Equities investment trust.
|
|
European equities are no longer obviously inexpensive, argues William Hobbs, but, an attractive dividend yield, a still expected earnings rebound and unevenly dissipating risks could reward investors.
|
|
Pfizers attempt to coax AstraZeneca’s major shareholders into forcing its board to negotiate on a potential takeover ultimately come to nothing
|
|
Fidelity Worldwide Investments has cut the costs of its equity range of index products in an effort to become the dominant player in the space.
|
|
With investors on the lookout for any signs that valuations wont be backed by earnings corporates cannot be seen to be underperforming.
|
|
Blackrock has publicly urged the AstraZeneca board to re-engage with potential buyer Pfizer
|
|
Results of European elections under way today are very unlikely to cause major disruption in markets, fund managers have said
|
|
Periodic mini-crises have forced central banks to take aggressive action to shore up their currencies, often at the expense of the outlook for domestic growth, writes Threadneedle’s Mark Burgess.
|
|
Company planning to raise £12m through London Stock Exchange IPO
|
|
David McFadzean of RBC Wealth Management favours the long game and looks at six funds that help balance a portfolio.
|
|